Corporation suffers from ADD. In "Good to great" by Collins, it would be characterized as a fox and definitely not an hedgehog. Software wise, it suffers from a nasty case of Not Invented Here syndrome so technical debt is very high bordering on unmanageable. Partnering with bigger players to integrate with existing and market leading solutions falls into the NIH case and gets discarded (in the era of GIT who buys a software company that has its own source control system based on CVS on DB ? ). Playing the financially motivated game of outsourcing work to low-cost countries and moving it around from low-cost to lower-cost adds up to long delays in product deliveries. Year after year R&D cuts.